A randomized study of high-dose pineal hormone melatonin alone versus high-dose melatonin plus low-dose angiotensin-(1-7) in untreatable advanced cancer patients
Abstract: The recent advances in the knowledge of the neuroendocrine control of the immune system and cancer growth have demonstrated the existence of several anticancer natural molecules in the human body, the most promising of them are the pineal hormone melatonin (MLT) and the enzymatic product...
Guardado en:
| Autores principales: | Lissoni, Paolo, Porro, Giorgio, Monzon, Alejandra, Lissoni, Arianna, Caddeo, Alberto, Messina, Giusy, Di Fede, Giuseppe, Valentini, Agnese, Simoes-e-Silva, Ana Cristina, Cardinali, Daniel Pedro |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Scientific Research and Community
2022
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/13670 |
| Aporte de: |
Ejemplares similares
-
A preliminary study of low-dose angiotensin 1-7 plus the pineal hormone melatonin in the treatment of human systemic diseases other than cancer and autoimmune pathologies
por: Lissoni, Paolo, et al.
Publicado: (2022) -
A phase II study of the pineal hormones melatonin and 5-methoxytryptamine plus cannabidiol in association with angiotensin 1-7 in the treatment of advanced solid tumour patients eligible for the only best supportive care
por: Lissoni, Paolo, et al.
Publicado: (2022) -
Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection?
por: Cardinali, Daniel Pedro
Publicado: (2019) -
High-dose dosimetry : proceedings of an International Symposium on High-Dose Dosimetry /
Publicado: (1985) -
High dose irradiation wholesomeness of food irradiated with doses above 10 kGy /
Publicado: (1999)